S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
NASDAQ:VAXX

Vaxxinity Stock Forecast, Price & News

$7.94
+0.58 (+7.88%)
(As of 01/19/2022 04:00 PM ET)
Add
Compare
Today's Range
$7.60
$9.88
50-Day Range
N/A
52-Week Range
$5.11
$22.77
Volume
6.64 million shs
Average Volume
783,691 shs
Market Capitalization
$995.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive VAXX News and Ratings via Email

Sign-up to receive the latest news and ratings for Vaxxinity and its competitors with MarketBeat's FREE daily newsletter.


Vaxxinity logo

About Vaxxinity

Vaxxinity Inc. is a biotechnology company pioneering a new class of immunotherapeutic vaccines to democratize health. Vaxxinity Inc. is based in DALLAS, Texas.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:VAXX
Fax
N/A
Employees
2,021
Year Founded
N/A

Sales & Book Value

Annual Sales
$560 thousand

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$995.63 million
Optionable
Not Optionable

Company Calendar

Last Earnings
12/22/2021
Today
1/20/2022
Next Earnings (Estimated)
3/24/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.83 out of 5 stars

Medical Sector

798th out of 1,415 stocks

Pharmaceutical Preparations Industry

381st out of 682 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -












Vaxxinity (NASDAQ:VAXX) Frequently Asked Questions

Is Vaxxinity a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vaxxinity in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Vaxxinity stock.
View analyst ratings for Vaxxinity
or view top-rated stocks.

When is Vaxxinity's next earnings date?

Vaxxinity is scheduled to release its next quarterly earnings announcement on Thursday, March 24th 2022.
View our earnings forecast for Vaxxinity
.

How were Vaxxinity's earnings last quarter?

Vaxxinity Inc (NASDAQ:VAXX) announced its quarterly earnings results on Wednesday, December, 22nd. The company reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.12.
View Vaxxinity's earnings history
.

What price target have analysts set for VAXX?

2 equities research analysts have issued 1 year target prices for Vaxxinity's shares. Their forecasts range from $18.00 to $21.00. On average, they expect Vaxxinity's stock price to reach $19.50 in the next year. This suggests a possible upside of 145.6% from the stock's current price.
View analysts' price targets for Vaxxinity
or view top-rated stocks among Wall Street analysts.

When did Vaxxinity IPO?

(VAXX) raised $90 million in an initial public offering (IPO) on Thursday, November 11th 2021. The company issued 6,000,000 shares at $14.00-$16.00 per share.

What is Vaxxinity's stock symbol?

Vaxxinity trades on the NASDAQ under the ticker symbol "VAXX."

When did the company's quiet period expire?

Vaxxinity's quiet period expired on Tuesday, December 21st. Vaxxinity had issued 6,000,000 shares in its public offering on November 11th. The total size of the offering was $78,000,000 based on an initial share price of $13.00. During the company's quiet period, underwriters and any insiders that worked on the IPO were restricted from issuing any research reports or earnings estimates for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Vaxxinity?

Shares of VAXX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vaxxinity's stock price today?

One share of VAXX stock can currently be purchased for approximately $7.94.

How much money does Vaxxinity make?

Vaxxinity has a market capitalization of $995.63 million and generates $560 thousand in revenue each year.

How many employees does Vaxxinity have?

Vaxxinity employs 2,021 workers across the globe.

What is Vaxxinity's official website?

The official website for Vaxxinity is www.vaxxinity.com.

How can I contact Vaxxinity?

The company can be reached via phone at 254-244-5739 or via email at [email protected].


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.